World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countries.
about
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis.Dried Saliva Spots: A Robust Method for Detecting Streptococcus pneumoniae Carriage by PCRHIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in UgandaCan combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and ZambiaThe case for addressing primary resistance mutations to non-nucleoside reverse transcriptase inhibitors to treat children born from mothers living with HIV in sub-Saharan Africa.Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis.Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda.HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis.Assessment of dried blood samples as an alternative less invasive method for detection of Hepatitis E virus marker in an outbreak setting.
P2860
Q35917578-100A6F05-CDFC-444B-987F-BE7DF3985ABEQ35965344-1C845AAF-A6A7-460D-A6A1-2FCA0A44585DQ36743624-A085F3E2-6116-4747-A0F7-012ABEC0BA4AQ37062207-E4CC606B-2851-49E8-A0FC-BF92B17C21E0Q37083998-A10064E3-70E6-4395-AEEF-6B410F555304Q37491651-ECAAF534-44D1-4908-AC69-D4CC7A8AADD7Q38875150-2371F96B-1491-4ABD-A78E-DE800B4EE58FQ38913062-DF697D96-EF6E-4F45-AB95-67D935B36213Q39297017-586760C0-FD9A-4F76-88D2-3946E637EFFDQ41919022-C976D3E5-4D45-487F-ABD7-DC33170DDABBQ42234861-F4DC5A80-CE01-4509-8867-D95A5FE1AFD7
P2860
World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countries.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
World Health Organization gene ...... in resource-limited countries.
@ast
World Health Organization gene ...... in resource-limited countries.
@en
type
label
World Health Organization gene ...... in resource-limited countries.
@ast
World Health Organization gene ...... in resource-limited countries.
@en
prefLabel
World Health Organization gene ...... in resource-limited countries.
@ast
World Health Organization gene ...... in resource-limited countries.
@en
P2093
P2860
P356
P1476
World Health Organization gene ...... in resource-limited countries.
@en
P2093
Deborah Persaud
Diane E Bennett
Martina Penazzato
Michael R Jordan
Pediatric HIV ResNet Working Group
Silvia Bertagnolio
P2860
P304
P356
10.1093/CID/CIS003
P407
P478
54 Suppl 4
P577
2012-05-01T00:00:00Z